Proton pump inhibitor use and risk of microscopic colitis - A nationwide Danish case-control study with 5751 cases

被引：0
|
作者：
Bonderup, O. [1 ]
Wigh, T. [2 ]
Fenger-Gron, M. [3 ,4 ]
Nielsen, G. Lauge [5 ]
机构：
[1] Reg Hosp Silkeborg, Ctr Diagnost, Gastroenterol Sect, Silkeborg, Denmark
[2] Reg Hosp Randers, Dept Med, Randers, Denmark
[3] Aarhus Univ, Res Unit Gen Practice, Aarhus, Denmark
[4] Aarhus Univ, Dept Clin Epidemiol, Aarhus, Denmark
[5] Hosp Himmerland, Dept Med, Farso, Denmark
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60718-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P598
引用
收藏
页码：S318 / S318
页数：1
相关论文
共 50 条
  • [21] Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study
    Pottegard, Anton
    Lash, Timothy L.
    Cronin-Fenton, Deirdre
    Ahern, Thomas P.
    Damkier, Per
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (09) : 2152 - 2161
  • [22] Proton pump inhibitor use and risk of colorectal cancer: A population-based, case-control study
    Robertson, Douglas J.
    Larsson, Heidi
    Friis, Soren
    Pedersen, Lars
    Baron, John A.
    Sorensen, Henrik T.
    [J]. GASTROENTEROLOGY, 2007, 133 (03) : 755 - 760
  • [23] PROTON PUMP INHIBITOR USE AND THE RISK OF CHOLANGITIS: A NATIONWIDE COHORT STUDY
    Min, Yang Won
    Song, Byeong Geun
    Kim, Tae-Se
    Park, Yewan
    Lee, Hyuk
    Min, Byung-Hoon
    Lee, Jun Haeng
    Rhee, Poong-Lyul
    Kim, Jae J.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S1043 - S1043
  • [24] Proton pump inhibitor use and the risk of cholangitis: A nationwide cohort study
    Min, Y. -W.
    Lee, H.
    Min, B. -H.
    Lee, J. -H.
    Rhee, P. -L.
    Kim, J. J.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30
  • [25] Proton pump inhibitor use associated with an increased risk of gout: A population-based case-control study
    Zhu, Kai-Jun
    Feng, Wei
    Ma, Xiao-Na
    Liao, Pei-Lun
    Lin, Chang-Song
    Huang, Jing-Yang
    Wei, James Cheng-Chung
    Xu, Qiang
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (09) : 1799 - 1806
  • [26] Proton Pump Inhibitors Are Associated with Increased Risk of Psoriasis: A Nationwide Nested Case-Control Study
    Li, Cheng-Yuan
    Dai, Ying-Xiu
    Chang, Yun-Ting
    Bai, Ya-Mei
    Tsai, Shih-Jen
    Chen, Tzeng-Ji
    Chen, Mu-Hong
    [J]. DERMATOLOGY, 2021, 237 (06) : 884 - 890
  • [27] Association between proton pump inhibitor use and risk of fracture: A population-based case-control study
    Kim, Jong Joo
    Jang, Eun Jin
    Park, Jiwon
    Sohn, Hyun Soon
    [J]. PLOS ONE, 2020, 15 (07):
  • [28] Dose-Dependent Proton Pump Inhibitor Exposure and Risk of Type 2 Diabetes: A Nationwide Nested Case-Control Study
    Kuo, Hsin-Ya
    Liang, Chih-Sung
    Tsai, Shih-Jen
    Chen, Tzeng-Ji
    Chu, Che-Sheng
    Chen, Mu-Hong
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (14)
  • [29] Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Danish Nested Case-Control Study
    Viggers, Rikke
    Al-Mashhadi, Zheer
    Starup-Linde, Jakob
    Vestergaard, Peter
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [30] Proton-Pump Inhibitor Induced Risk of Liver Cancer: A Nested Case-Control Study
    Joni Shao, Yu-Hsuan
    Demissie, Kitaw
    Wu, Szu-Yuan
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 598 - 599
12345